• Je něco špatně v tomto záznamu ?

The Impact of Dextran Sodium Sulfate-Induced Gastrointestinal Injury on the Pharmacokinetic Parameters of Donepezil and Its Active Metabolite 6-O-desmethyldonepezil, and Gastric Myoelectric Activity in Experimental Pigs

J. Bures, I. Tacheci, J. Kvetina, V. Radochova, L. Prchal, D. Kohoutova, M. Valis, M. Novak, R. Dolezal, M. Kopacova, S. Rejchrt, V. Sestak, V. Knoblochova, E. Peterova, J. Zdarova Karasova

. 2021 ; 26 (8) : . [pub] 20210409

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc21018849

Grantová podpora
18-13283S Grantová Agentura České Republiky

Gastrointestinal side effects of donepezil, including dyspepsia, nausea, vomiting or diarrhea, occur in 20-30% of patients. The pathogenesis of these dysmotility associated disorders has not been fully clarified yet. Pharmacokinetic parameters of donepezil and its active metabolite 6-O-desmethyldonepezil were investigated in experimental pigs with and without small intestinal injury induced by dextran sodium sulfate (DSS). Morphological features of this injury were evaluated by a video capsule endoscopy. The effect of a single and repeated doses of donepezil on gastric myoelectric activity was assessed. Both DSS-induced small intestinal injury and prolonged small intestinal transit time caused higher plasma concentrations of donepezil in experimental pigs. This has an important implication for clinical practice in humans, with a need to reduce doses of the drug if an underlying gastrointestinal disease is present. Donepezil had an undesirable impact on porcine myoelectric activity. This effect was further aggravated by DSS-induced small intestinal injury. These findings can explain donepezil-associated dyspepsia in humans.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21018849
003      
CZ-PrNML
005      
20210830100430.0
007      
ta
008      
210728s2021 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/molecules26082160 $2 doi
035    __
$a (PubMed)33918638
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Bures, Jan $u 2nd Department of Internal Medicine-Gastroenterology, Charles University Faculty of Medicine in Hradec Kralove and University Hospital, 500 03 Hradec Kralove, Czech Republic
245    14
$a The Impact of Dextran Sodium Sulfate-Induced Gastrointestinal Injury on the Pharmacokinetic Parameters of Donepezil and Its Active Metabolite 6-O-desmethyldonepezil, and Gastric Myoelectric Activity in Experimental Pigs / $c J. Bures, I. Tacheci, J. Kvetina, V. Radochova, L. Prchal, D. Kohoutova, M. Valis, M. Novak, R. Dolezal, M. Kopacova, S. Rejchrt, V. Sestak, V. Knoblochova, E. Peterova, J. Zdarova Karasova
520    9_
$a Gastrointestinal side effects of donepezil, including dyspepsia, nausea, vomiting or diarrhea, occur in 20-30% of patients. The pathogenesis of these dysmotility associated disorders has not been fully clarified yet. Pharmacokinetic parameters of donepezil and its active metabolite 6-O-desmethyldonepezil were investigated in experimental pigs with and without small intestinal injury induced by dextran sodium sulfate (DSS). Morphological features of this injury were evaluated by a video capsule endoscopy. The effect of a single and repeated doses of donepezil on gastric myoelectric activity was assessed. Both DSS-induced small intestinal injury and prolonged small intestinal transit time caused higher plasma concentrations of donepezil in experimental pigs. This has an important implication for clinical practice in humans, with a need to reduce doses of the drug if an underlying gastrointestinal disease is present. Donepezil had an undesirable impact on porcine myoelectric activity. This effect was further aggravated by DSS-induced small intestinal injury. These findings can explain donepezil-associated dyspepsia in humans.
650    _2
$a zvířata $7 D000818
650    _2
$a kapslová endoskopie $7 D053704
650    _2
$a síran dextranu $7 D016264
650    _2
$a donepezil $x chemie $x farmakokinetika $x farmakologie $7 D000077265
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a gastrointestinální trakt $x účinky léků $x patologie $x patofyziologie $7 D041981
650    _2
$a indany $x metabolismus $7 D007189
650    12
$a metabolom $x účinky léků $7 D055442
650    12
$a migrující myoelektrický komplex $x účinky léků $7 D016065
650    _2
$a piperidiny $x metabolismus $7 D010880
650    _2
$a žaludek $x účinky léků $x patofyziologie $7 D013270
650    _2
$a prasata $7 D013552
655    _2
$a časopisecké články $7 D016428
700    1_
$a Tacheci, Ilja $u 2nd Department of Internal Medicine-Gastroenterology, Charles University Faculty of Medicine in Hradec Kralove and University Hospital, 500 03 Hradec Kralove, Czech Republic
700    1_
$a Kvetina, Jaroslav $u 2nd Department of Internal Medicine-Gastroenterology, Charles University Faculty of Medicine in Hradec Kralove and University Hospital, 500 03 Hradec Kralove, Czech Republic
700    1_
$a Radochova, Vera $u Animal Laboratory, Faculty of Military Health Sciences, University of Defence, 500 01 Hradec Kralove, Czech Republic
700    1_
$a Prchal, Lukas $u Centre of Biomedical Research, University Hospital, 500 05 Hradec Kralove, Czech Republic
700    1_
$a Kohoutova, Darina $u 2nd Department of Internal Medicine-Gastroenterology, Charles University Faculty of Medicine in Hradec Kralove and University Hospital, 500 03 Hradec Kralove, Czech Republic $u The Royal Marsden Hospital NHS Foundation Trust, London SW3 6JJ, UK
700    1_
$a Valis, Martin $u Department of Neurology, Charles University Faculty of Medicine in Hradec Kralove and University Hospital, 500 03 Hradec Kralove, Czech Republic
700    1_
$a Novak, Martin $u Centre of Biomedical Research, University Hospital, 500 05 Hradec Kralove, Czech Republic $u Department of Pharmaceutical Chemistry and Pharmaceutical Analysis, Charles University Faculty of Pharmacy, 500 05 Hradec Kralove, Czech Republic
700    1_
$a Dolezal, Rafael $u Centre of Biomedical Research, University Hospital, 500 05 Hradec Kralove, Czech Republic
700    1_
$a Kopacova, Marcela $u 2nd Department of Internal Medicine-Gastroenterology, Charles University Faculty of Medicine in Hradec Kralove and University Hospital, 500 03 Hradec Kralove, Czech Republic
700    1_
$a Rejchrt, Stanislav $u 2nd Department of Internal Medicine-Gastroenterology, Charles University Faculty of Medicine in Hradec Kralove and University Hospital, 500 03 Hradec Kralove, Czech Republic
700    1_
$a Sestak, Vit $u Department of Clinical Biochemistry and Diagnostics, University Hospital Hradec Kralove, 500 05 Hradec Kralove, Czech Republic
700    1_
$a Knoblochova, Veronika $u 2nd Department of Internal Medicine-Gastroenterology, Charles University Faculty of Medicine in Hradec Kralove and University Hospital, 500 03 Hradec Kralove, Czech Republic
700    1_
$a Peterova, Eva $u 2nd Department of Internal Medicine-Gastroenterology, Charles University Faculty of Medicine in Hradec Kralove and University Hospital, 500 03 Hradec Kralove, Czech Republic
700    1_
$a Zdarova Karasova, Jana $u Centre of Biomedical Research, University Hospital, 500 05 Hradec Kralove, Czech Republic $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence, 500 01 Hradec Kralove, Czech Republic
773    0_
$w MED00180394 $t Molecules (Basel, Switzerland) $x 1420-3049 $g Roč. 26, č. 8 (2021)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33918638 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210728 $b ABA008
991    __
$a 20210830100431 $b ABA008
999    __
$a ok $b bmc $g 1689823 $s 1139295
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 26 $c 8 $e 20210409 $i 1420-3049 $m Molecules $n Molecules $x MED00180394
GRA    __
$a 18-13283S $p Grantová Agentura České Republiky
LZP    __
$a Pubmed-20210728

Najít záznam

Citační ukazatele

    Možnosti archivace